3rd Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$1,420,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

- Korea-US Free Trade Agreement - Issues related to current and future trade negotiations. - TransPacific Partnership trade negotiations. - Pending legislation regarding the extension of permanent normal trade relations to Russia.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Financial Institutions/Investments/Securities FIN

- HR 1062, "The Burdensome Data Collection Relief Act", regarding all provisions.

LobbyistCovered position, as disclosed
DAVID KAVANAUGH —

Contacted: Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1062 (112th)

Taxation/Internal Revenue Code TAX

- Issues regarding tax reform. - HR 605, "The Patients' Freedom to Choose Act", regarding all provisions. - HR 436, "Protect Medical Innovation Act of 2011", regarding all provisions. - HR 488, "Save Our Medical Devices Act of 2011", regarding all provisions. - HR 734, "To amend the Internal Revenue Code of 1986 to repeal the medical device tax, and for other purposes", regarding all provisions. - S 17, "Medical Device Access and Innovation Protection Act", regarding all provisions. - S 262, "A bill to repeal the excise tax on medical device manufacturers", regarding all provisions. - HR 942, "American Research and Competitiveness Act of 2011", regarding all provisions - Issues related to tax legislation. - Issues related to the President's proposed "Job Bill" (2011) - S 1368/ HR 2529, "Restoring Access to Medication Act", regarding all provisions. - S 1584, "Drug Safety and Accountability Act of 2011", regarding all provisions. - HR 2245, "Preserving Access to Life-Saving Medication Act", regarding all provisions. - Issues related to Ways and Means tax reform discussion draft. - HR 2735, "To amend the Internal Revenue Code of 1986 to make permanent the look-through treatment of payments between related controlled foreign corporations", regarding all provisions. - S 1577, "Greater Research Opportunities With Tax Help Act", regarding all provisions. - PL 112-96, "Middle Class Tax Relief and Job Creation Act of 2012", provisions regarding Medicare clinical laboratory services. - HR 1864, "Mobile Workforce State Income Tax Simplification Act of 2011", regarding all provisions. - S 2091, "United States Job Creation and International Tax Reform Act of 2012", regarding all provisions.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DON BOHN —
BRIAN BURNS —
JULIE D COHEN —
KIMBERLY DAVIS —
DARREL C JODREY —
DAVID KAVANAUGH —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2245 (112th), H.R. 2529 (112th), H.R. 605 (112th), H.R. 2735 (112th), H.R. 436 (112th), H.R. 1864 (112th), H.R. 488 (112th), H.R. 942 (112th), H.R. 734 (112th)

Health Issues HCR

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - Issues related to Physician Payment Sunshine provisions. - Issues generating antibiotic incentives. - HR 1282, "Generating Antibiotics Incentives Now Act of 2011", regarding all provisions. - Issues related to the "Regulation & Reimbursement of Diagnostics", regarding all provisions. - Implementation of the Health Care Reform Bill, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 2960, "National Diabetes Clinical Care Commission Act", regarding all provisions. - HR 3026, "Safeguarding America's Pharmaceutical Act of 2011", regarding all provisions. - Prescription Drug User Fee Act, regarding all provisions - Personalized Medicine Incentives and Regulation. - Issues related to Alzheimer's research. - HR 2939, "Pharmaceutical Stewardship Act of 2011", regarding all provisions. - HR 3497, "MODERN Cures Act of 2011", regarding all provisions. - HR 3207, "Modernizing Laboratory Test Standards for Patients Act of 2011", regarding all provisions. - S 1700, "Medical Device Regulatory Improvement Act", regarding all provisions. - S 1865, "Patient Access to Medical Innovation Act", regarding all provisions. - S 1995, "Medical Device Patient Safety Act", regarding all provisions. - Issues related to vision care coverage under PPACA. - Medical Device User Fee Act Reauthorization. - HR 1483, "The Drug Safety Enhancement Act of 2011", regarding all provisions. - HR 3847, "Safety of Untested and New Devices Act of 2012", regarding all provisions. - HR 3975, "A bill to extend provisions of the Pediatric Medical Device Safety and Improvement Act of 2007", regarding all provisions. - S 2113, "A bill to empower the Food and Drug Administration to ensure a clear and effective pathway that will encourage innovative products to benefit patients and improve public health." regarding all provisions. - S 2193, "Ensuring Safe Medical Devices for Patients", regarding all provisions. - HR 5, "Protecting Access to Healthcare (PATH) Act", regarding all provisions. - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - HR 5937, "Breast Cancer Patient Education Act of 2012", regarding all provisions. - HR 5998, "USPSTF Transparency and Accountability Act of 2012", regarding all provisions. - S 3187, "Food and Drug Administration Safety and Innovation Act", regarding all provisions. - S 2516, "Food and Drug Administration Safety and Innovation Act", regarding all provisions.

Contacted: Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: H.R. 5 (112th), H.R. 3497 (112th), H.R. 3207 (112th), H.R. 5998 (112th), H.R. 452 (112th), H.R. 5937 (112th), H.R. 1282 (112th), H.R. 3975 (112th), H.R. 2939 (112th), H.R. 1483 (112th), H.R. 3847 (112th), H.R. 2960 (112th), H.R. 3026 (112th)

Medicare/Medicaid MMM

- HR 905/ S 733, "To Amend Part B or Title XVIII of the Social Security Act to exclude customary prompt pay discounts from Manufacturers to Wholesalers from the average sales price for drugs & biologicals under Medicare", regarding all provisions. - HR 1041, "The Fairness in Medicare Bidding Act", regarding all provisions. - Issues related to Medicare reimbursement for Clinical Laboratory Services. - HR 1041, "Fairness in Medicare Bidding Act", regarding all provisions. - Medicare Part D Letter - HR 452, "Medicare Decisions Accountability Act of 2011", regarding all provisions. - S 668, "Health Care Bureaucrats Elimination Act", regarding all provisions. - Issues related to Physician-owned Companies that manufacture or distribute medical devices. - S 1468/ HR 2787, "Medicare Diabetes Self-Management Training Act of 2011", regarding all provisions. - PL 112-96, "Middle Class Tax Relief and Job Creation Act of 2012", provisions regarding Medicare clinical laboratory services. - Issues related to implantable medical devices. - HR 5998, "USPSTF Transparency and Accountability Act of 2012", regarding all provisions.

LobbyistCovered position, as disclosed
JULIE D COHEN —
KIMBERLY DAVIS —
LAURYL DODSON JACKSON —
MARK REESE —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 905 (112th), H.R. 452 (112th), H.R. 1041 (112th), H.R. 2787 (112th), H.R. 5998 (112th)

Budget/Appropriations BUD

- Issues related to ADAP funding. - Issues related to FDA funding. - Issues related to Alzheimer's funding. - Issues related to deficit reductions/ fiscal cliff

LobbyistCovered position, as disclosed
BRIAN BURNS —
JULIE D COHEN —
DARREL C JODREY —
CHARLES NAU —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Environment/Superfund ENV

- Issues related to chemicals in the environment - Issues related to the Toxic Substances Control Act - S. 847, "Safe Chemicals Act of 2011", regarding all provisions.

LobbyistCovered position, as disclosed
GREGORY ARONIN —
DARREL C JODREY —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE

Bills named: S. 847 (112th)

Consumer Issues/Safety/Products CSP

- Issues related to dextromethorphan - Issues related to Pseudoephedrine - Issues related to the regulation of Cosmetic Products. - HR 2359, "Safe Cosmetics Act of 2011", regarding all provisions. - HR 4395, "Cosmetic Safety Amendments Act of 2012", regarding all provisions. - HR 4262, "Cosmetic Safety Enhancement Act of 2012", regarding all provisions. - S 3376, "Prevent Abuse of Cough Treatment Act of 2012", regarding all provisions.

LobbyistCovered position, as disclosed
GREGORY ARONIN —
DON BOHN —
DARREL C JODREY —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC)

Bills named: H.R. 4395 (112th), H.R. 4262 (112th), H.R. 2359 (112th)

Torts TOR

- HR 5, "Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011", regarding all provisions. - HR 675, "Strengthening Medicare Anti-Fraud Measures Act of 2011", regarding all provisions. - Issues regarding Health Courts

LobbyistCovered position, as disclosed
GREGORY ARONIN —
BRIAN BURNS —

Contacted: SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 5 (112th), H.R. 675 (112th)

Law Enforcement/Crime/Criminal Justice LAW

- Issues regarding the theft of medical products. - S 1002, "SAFE DOSES Act", regarding all provisions. - HR 4223, "Safe Doses Act", regarding all provisions.

LobbyistCovered position, as disclosed
MARK REESE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Bills named: H.R. 4223 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.